Serious bradyarrhythmia that was possibly induced by lopinavir-ritonavir in 2 patients with acquired immunodeficiency syndrome

Clin Infect Dis. 2002 Aug 15;35(4):488-90. doi: 10.1086/341975. Epub 2002 Jul 17.

Abstract

We describe 2 patients with acquired immunodeficiency syndrome who had potentially fatal bradyarrhythmia that occurred shortly after commencement of antiretroviral therapy. Lopinavir-ritonavir was the only drug that both patients were using.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Adult
  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use
  • Bradycardia / chemically induced*
  • Humans
  • Lopinavir
  • Male
  • Middle Aged
  • Pyrimidinones / adverse effects*
  • Pyrimidinones / therapeutic use
  • Ritonavir / adverse effects*
  • Ritonavir / therapeutic use

Substances

  • Anti-HIV Agents
  • Pyrimidinones
  • Lopinavir
  • Ritonavir